Oncology & Cancer

Anti-inflammatory drug may fight breast cancer

The anti-inflammatory drug celecoxib may be a useful additional treatment for people with breast cancer, Dutch researchers report at the IMPAKT Breast Cancer Conference in Brussels.

Oncology & Cancer

Overall survival up for melanoma brain metastases

(HealthDay)—Overall survival (OS) for patients with melanoma brain metastases (MBM) has improved significantly since 2000, according to a study published online Oct. 12 in Cancer.

Oncology & Cancer

Combining immunotherapies effective against mouse model of cancer

Rhabdomyosarcoma, a cancer made up of cells that normally develop into skeletal muscles, is the most common soft tissue cancer in children. If it is detected early and localized in certain areas, rhabdomyosarcoma is usually ...

Medical research

The link between protein aggregation and aging

Not only does our way of life determine how long we live but so too does our genetic material. Of particular importance here is a genetic program that is controlled by the insulin receptor. A team of researchers from the ...

Genetics

Scientists identify first gene in programmed axon degeneration

Degeneration of the axon and synapse, the slender projection through which neurons transmit electrical impulses to neighboring cells, is a hallmark of some of the most crippling neurodegenerative and brain diseases such as ...

Medical research

Researchers uncover a new role of 'moonlighting' proteins

Although known to regulate fundamental cellular processes in humans, including cell growth, division and programmed cell death, the protein group known as chloride intracellular channel (CLIC) proteins is yet to be fully ...

Oncology & Cancer

Ovarian cancer: Potential therapeutic target identified

A gene called DOT1L appears to play a role in progression and severity of ovarian cancer, and inhibitors of the DOT1L enzyme may offer a new therapeutic approach for the disease, University of Alabama at Birmingham researchers ...

page 6 from 19